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†Department of Molecular and Cellular Biology and ‡Department of Physics, University of Guelph, Guelph, Ontario, CanadaABSTRACT The 18.5-kDa myelin basic protein (MBP), the most abundant isoform in human adult myelin, is a multifunctional,
intrinsically disordered protein that maintains compact assembly of the sheath. Solution NMR spectroscopy and a hydrophobic
moment analysis of MBP’s amino-acid sequence have previously revealed three regions with high propensity to form strongly
amphipathic a-helices. These regions, located in the central, N- and C-terminal parts of the protein, have been shown to
play a role in the interactions of MBP with cytoskeletal proteins, Src homology 3-domain-containing proteins, Ca2þ-activated
calmodulin (Ca2þ-CaM), and myelin-mimetic membrane bilayers. Here, we have further characterized the structure-function
relationship of these three domains. We constructed three recombinant peptides derived from the 18.5-kDa murine MBP:
(A22–K56), (S72–S107), and (S133–S159) (which are denoted a1, a2, and a3, respectively). We used a variety of biophysical
methods (circular dichroism spectroscopy, isothermal titration calorimetry, transmission electron microscopy, fluorimetry, and
solution NMR spectroscopy and chemical shift index analysis) to characterize the interactions of these peptides with actin
and Ca2þ-CaM. Our results show that all three peptides can adopt a-helical structure inherently even in aqueous solution.
Both a1- and a3-peptides showed strong binding with Ca2þ-CaM, and both adopted an a-helical conformation upon interaction,
but the binding of the a3-peptide appeared to be more dynamic. Only the a1-peptide exhibited actin polymerization and bundling
activity, and the addition of Ca2þ-CaM resulted in depolymerization of actin that had been polymerized by a1. The results of this
study proved that there is an N-terminal binding domain in MBP for Ca2þ-CaM (in addition to the primary site located in the
C-terminus), and that it is sufficient for CaM-induced actin depolymerization. These three domains of MBP represent molecular
recognition fragments with multiple roles in both membrane- and protein-association.INTRODUCTIONMultiple sclerosis is the major demyelinating disease of
humans characterized by degradation of the myelin sheath
due to autoimmune attack (1). The most studied candidate
autoantigen is the classic 18.5-kDa myelin basic protein
(MBP) isoform (the most abundant in adult myelin) (2–6).
This isoform exists as a number of charge components or
isomers (denoted C1–C8) due to a wide variety of post-
translational modifications, such as methylation, phosphory-
lation, and deimination (7). The least posttranslationally
modified isomer with a net positive charge ofþ19 at neutral
pH is the focus of this study,whichwewill henceforth refer to
as ‘‘MBP’’ or ‘‘rmC1’’ (the unmodified recombinant murine
C1 charge component of MBP) (8). Due to its high net posi-
tive charge and conformational adaptability to its environ-
ment, MBP is an intrinsically disordered protein (2,5,6,9).
MBP is an essential structural protein in the central nervous
system, where it maintains the tight multilamellar assembly
of themyelin sheath by adhesion of the apposing cytoplasmic
leaflets of the oligodendrocyte membrane (10,11), and is
multifunctional (3,4,6), like other intrinsically disordered
proteins.Submitted February 2, 2011, and accepted for publication July 22, 2011.
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0006-3495/11/09/1248/9 $2.00It has been shown in different in vitro studies that MBP
interacts directly with cytoskeletal proteins (actin and
tubulin) (12–17), Ca2þ-activated calmodulin (Ca2þ-CaM)
(18–22), Src homology 3 (SH3)-domain containing proteins
(23,24), and divalent metal cations (25), and either directly
or indirectly with voltage-operated calcium channels (26).
Moreover, MBP has been shown to interact simultaneously
with actin and lipid vesicles, thus supporting its suggested
role in the organization of the actin cytoskeleton, and in
tethering it to the inner leaflet of the oligodendrocyte
membrane (12,13,27). In oligodendrocytes cultured from
the shiverer mouse (which lacks MBP), actin filaments
appeared to be disorganized, and the cell processes were
smaller than normal with a larger cell body (28–30). Our
recent studies with cultured oligodendrocytes have shown
that the 18.5-kDa MBP isoform associates with the cyto-
skeleton during phorbol ester-induced membrane ruffling
(31), and that SH3-ligand mutations of MBP result in atten-
uated affinity for Fyn kinase and alter process differentiation
and protein localization (32). Altogether, these diverse
observations suggest that the interaction of MBP with cyto-
skeletal and signaling proteins is crucial for oligodendrocyte
function, and myelin formation and maintenance.
In aqueous solution, MBP adopts an extended conforma-
tion and circular dichroism (CD) spectroscopy indicates a
mainly random coil conformation. However, different seg-
ments of MBP gain ordered secondary structure upon inter-
action with its biological partners (reviewed in (2,5,6)), suchdoi: 10.1016/j.bpj.2011.07.035
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(19,22). These intermolecular associations may involve
preformed structural elements such as a-helices, and/or
an induced fit, i.e., coupled folding and binding. This
idea has been encapsulated in the Molecular Recognition
Fragments (MoRF, specifically a-MoRF) hypothesis for
intrinsically disordered proteins (37–39). In this conceptual
framework, a hydrophobic moment analysis of MBP’s
amino-acid sequence reveals three regions in the MBP
sequence with high propensity to form strongly amphipathic
a-helices located in the N- and C-termini, and in the central
part of the protein (see Fig. S1 in the Supporting Material)
(5,6). This analysis is strongly supported by experimental
studies using electron paramagnetic resonance (EPR) and
solution and solid-state NMR spectroscopy, which showed
that these regions interact with myelin-mimetic lipid
membranes and adopt an a-helical structure (19,33,34,36,
40,41). Additionally, these regions were shown to play a
role in the interactions of MBP with other partners. The
central region of MBP represents a primary immunodomi-
nant epitope (Pro82Pro93) and the proline-rich region
immediately following it forms a transient poly-proline
type II conformation that represents a ligand for SH3-
domain binding proteins (5,24,32,42–44). Recently, the
N- and C-terminal regions of MBP were shown to play
key roles in actin polymerization and binding (16,17), and
the C-terminus in binding to Ca2þ-activated CaM (19).
Here, we have focused on the characterization of the three
described amphipathic a-helical MBP domains in terms of
the relationship between their potential structure and func-
tion. For the purpose of this study, we constructed three re-
combinant peptides derived from the 18.5-kDa murine MBP
sequence: (A22–K56), (S72–S107), and (S133–S159),
which are denoted a1, a2, and a3, respectively. In our
numbering convention, the N-terminal methionine is not
counted because it is cleaved (45). Our results here show
that all three peptides can adopt a-helical structure inher-
ently, even in aqueous solution. Although both the
N-terminal a1- and C-terminal a3-peptides showed strong
binding with Ca2þ-CaM, only a1 exhibited actin polymeri-
zation and bundling activity. Actin that was polymerized by
a1 could subsequently be depolymerized by Ca2þ-CaM.
Solution NMR spectroscopy showed major structural reor-
ganizations of both the a1- and a3-peptides upon binding
to Ca2þ-CaM, but with different degrees of interaction.MATERIALS AND METHODS
Fully detailed Materials and Methods are provided in the Supporting Mate-
rial available online. Briefly, three different regions of murine 18.5-kDa
MBP coding for amino acids (A22–K56), (S72–S107), and (S133–S159)
were cloned into the Champion pET Small Ubiquitin MOdifier (SUMO)
Expression System (Invitrogen Life Technologies, Burlington, ON) and
were named a1, a2, and a3, respectively. The plasmids coding for these
SUMO-MBP-a-peptide fusion proteins were transformed into Escherichia
coli BL21-CodonPlus (DE3)-RP cells (Stratagene, La Jolla, CA) and wereexpressed and purified as detailed in the Supporting Material. CD spectros-
copy was used to evaluate the secondary structure of each peptide in
aqueous solution, with trifluoroethanol to stabilize a-helices, and in dodecyl
phosphocholine (DPC) micelles as a membrane-mimetic condition.
Isothermal titration calorimetry was used to probe the interaction of
Ca2þ-activated CaM (Ca2þ-CaM) with each peptide.
Actin polymerization induced by each peptide was followed by
measuring an increase in fluorescence intensity of pyrene-labeled actin
via an automated microplate fluorescence reader, and overall morphology
evaluated by transmission electron microscopy. Actin bundling was as-
sessed by a centrifugation and gel electrophoretic assay, and the structural
changes of two MBP-derived peptides (a1 and a3) interacting with Ca2þ-
CaM were assessed by CD and solution NMR spectroscopy.RESULTS AND DISCUSSION
Expression and purification of a1, a2, and a3
Three peptides a1 (A22-K56), a2 (S72–S107), and a3
(S133–S159) from the 18.5-kDa murine MBP amino-acid
sequence were designed to include three regions (T33-
D46, V83-T92, and V142-L154) that had been previously
suggested to adopt a strongly amphipathic a-helical struc-
ture (see Fig. S1). One of the methods to prevent in vivo
degradation of recombinant short polypeptides during
expression in prokaryotic cells (E. coli) is to express them
as fusion proteins from which target peptides can be
released by enzymatic cleavage. This strategy also enables
stable isotope-labeling for NMR spectroscopy (46). Here,
we used the small ubiquitin-related modifier (SUMO) linked
with a hexahistidine tag to overexpress MBP-a-peptides in
E. coli BL21-CodonPlus (DE3)-RP cells.
The advantages of this expression system lie in its
simplicity and ability to produce isotopically labeled
peptides at relatively high yield, and without any additions
related to the purification protocol (47,48). Using this
system, we were able to express up to 130 mg of SUMO-
peptide-fused products per liter of culture and, using a native
lysis procedure followed by immobilized metal affinity
chromatography (using Ni-NTA resin), purify them from
the whole bacterial lysates (see Fig. S2, A, C, and E, left-
hand side). In the subsequent step, SUMO was enzymati-
cally removed in a reaction with specific SUMO protease
I (Ulp1, kindly provided by Dr. C. D. Lima, Sloan-Kettering
Institute, NY).
To achieve complete cleavage, we applied 1 mg of
protease to 1 mg of fused proteins, and the reaction mixtures
were incubated with protease at 30C for 3 h. The efficiency
of proteolytic cleavage was assessed by Tricine-polyacryl-
amide gel electrophoresis (see Fig. S2, A, C, and E, right-
hand side), and the peptides were further purified by
subtractive chromatography using the same Ni-NTA resin
once again. During this chromatography step, the cleaved
SUMO-tag along with the SUMO protease bound to the
column, because they both contained hexahistidine affinity
tags, whereas the untagged peptides of interest were recov-
ered in the flowthrough and wash fractions. Peptides wereBiophysical Journal 101(5) 1248–1256
1250 Bamm et al.further purified by high-performance liquid chromatography
(HPLC) and the final purity was assessed by rechromatogra-
phy using HPLC (see Fig. S2, B, D, and F). The retention
times from the HPLC column for the a1-, a2-, and
a3-peptides appeared to be 19.6 min (35.6% acetonitrile),
18.7 min (34.7% acetonitrile), and 16.1 min (32.1% acetoni-
trile), respectively, and the purity of the peptides was 99.5%,
98.9%, and 98.7%, respectively. This protocol yielded ~13–
18 mg of a2- and a3-peptides, and a slightly lower amount
(~6–12 mg) of a1 per liter of culture. To confirm the molec-
ular mass of the purified peptides, matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry was
used, yielding 3822.99 Da (calculated 3823.3 Da),
3969.98 Da (calculated 3970.4 Da), and 2841.38 Da (calcu-
lated 2840.1 Da) for a1, a2, and a3, respectively.Secondary structure analysis of MBP-a-peptides
in different environments
CD spectroscopy ofMBP in aqueous solution has shown that
its conformation is predominantly a random coil, but the
protein undergoes some conformational changes and adopts
a certain degree of ordered secondary structure in the pres-
ence of detergents or lipids (2,40,49). As stated above, the
primary role of MBP is the maintenance of the compact
myelin assembly surrounding axons by adhesion of the
apposing cytoplasmic faces of the oligodendrocyte mem-
branes. Therefore, a physiologically more relevant environ-
ment of 18.5-kDa MBP is membranous; however, most
solution spectroscopicmethods used to analyze protein struc-
ture are not applicable toMBP in its native-mimetic environ-
ment because protein-lipid aggregation produces semisolid
assemblies (see (2,9,40)). Twowidely acceptedways to over-
come this problem are the use of 2,2,2-trifluoroethanol
(TFE), a membrane-mimetic organic solvent (50–52), or do-
decyl phosphocholine (DPC), a micelle-forming lysolipid.
One of the goals of this study was to confirm that the MBP
segments that have been proposed to adopt an a-helical
conformation in the full-length protein, based on diverse
experimental evidence, indeed do so in aqueous and/or
membrane-mimetic environments.
For this purpose, we compared CD spectra of a1-, a2-,
and a3-peptides in aqueous buffer and a membrane-mimetic
(TFE and DPC) environment (see Fig. S3). The typical CD
spectrum of full-length 18.5-kDa mMBP in aqueous solu-
tion is characterized by a negative peak with a minimum
at 197 nm, resulting from a mostly random coil structure
(8,49). However, here it was obvious that all three peptides,
even in the aqueous buffer, exhibited a much higher pro-
portion of ordered secondary structure than full-length
18.5-kDa murine MBP, because the minima for all three
peptides were observed at ~205 nm. In the experiments
where we added an increased amount of TFE to the buffered
peptides, a dramatic effect was observed. Even at as low as
10% TFE, one can see a shift toward increased a-helicalBiophysical Journal 101(5) 1248–1256conformation, and at higher concentrations of TFE, all three
peptides exhibited well-pronounced a-helical conforma-
tions characterized by troughs at ~207 nm and ~222 nm.
The mechanism by which TFE stabilizes (or sometimes
induces) secondary structure is based on reduction of the
dielectric constant around the peptide, thus allowing forma-
tion of hydrogen bonds between residues in the polypeptide
chain (50). Similarly, protein-lipid interactions stabilize
and/or induce hydrogen bonds between residues by exclu-
sion of bulk solvent from the protein surroundings (53).
Thus, not surprisingly, DPC produced very similar effects
on the secondary structure of all three MBP-a-peptides.
However, the most pronounced effect was observed at
a concentration of DPC higher than the critical micelle
concentration (1 mM), and the most prominent a-helical
conformations were achieved when there was at least one
micelle per molecule of MBP-a-peptide (each DPC micelle
contains 40–60 lipid molecules). Altogether, these consider-
ations mean that the change in the secondary structure of the
three MBP-a-peptides reflects their potential to adopt the
same conformation in their native membrane environment.
In general, it would be expected that the interactions of
each of the a1-, a2-, and a3-peptides with lipid bilayers
would be subtly different (52,54), and that posttranslational
modifications in each domain would also play a role in
modulating the binding (5,6,33,34,55).
Here, the a3-peptide—the C-terminal segment of MBP
that was considered to contain the primary CaM-binding
domain (18,19)—adopted the highest degree of a-helical
conformation, particularly in the presence of TFE. This
capability, in fact, can play an extremely important role in
recognition of this MBP region by Ca2þ-activated CaM,
because in its canonical mode of interaction, Ca2þ-CaM
recognizes a-helical segments and closes its lobes around
them (56,57). In the full-length 18.5-kDa protein, this region
has been shown by EPR spectroscopy to be a-helical in asso-
ciation with phospholipid membranes, and to interact with
Ca2þ-CaM both in solution and on a membrane (33,58).CaM binding to MBP-a-peptides
It has been previously demonstrated by numerous techniques
that MBP interacts with CaM in a Ca2þ-dependent manner
(see (18,19,21,22), and references therein). Although the
primary CaM-binding site of MBP was initially predicted
to be a C-terminal segment (Lys132Arg167), several ex-
perimental results suggested that there was more than
one binding site (21,58,59). Solution NMR investigations
demonstrated that the C-terminal segment (Pro120Arg160)
was the primary binding site for Ca2þ-CaM in solution, as
indicated by contiguous chemical shift perturbations (19).
Those studies were complemented by in silico molecular
modeling and EPR spectroscopy that suggested three seg-
ments of MBP (Arg41Arg52, Pro82Pro93, and Thr147
Asp158) modeled as a-helices could bind Ca2þ-CaM with
MBP Functional Domains 1251favorable energetics (58). The interaction of the central
immunodominant epitope (Pro82Pro93), however, was
shown to be energetically unfavorable when modeled in the
extended conformation.
The peptides that we used here were designed to include
all three potential interaction sites. We used isothermal
titration calorimetry to characterize the binding parameters
of CaM with the MBP-a-peptides (Fig. 1, A and B). All
experiments in this section were carried out in aqueous
buffer, where the presence of a-helical structure wasFIGURE 1 Isothermal titration calorimetry and circular dichroism spec-
troscopy of MBP-derived peptides interacting with Ca2þ-activated CaM. A
100 mM protein solution (20 mM HEPES-KOH, pH 7.4, 100 mM KCl,
5 mM CaCl2) was titrated with 1 mM solution of a1-peptide (A) and
a3-peptide (B) at 30C (---). The Ca2þ-dependency of the binding was
assessed in the same reaction protocol, but now in the Ca2þ-depleted buffer
(20 mM HEPES-KOH, pH 7.4, 100 mM KCl, 8 mM EDTA, 2 mM EGTA)
(-;-). The data were fitted to the software Origin’s one-set-of-sites model
(OriginLab, Northampton, MA). All parameters are summarized in Table
S1. The CD spectra of 131 mM and 176 mMCa2þ-CaM in the absence (solid
lines) or presence (dashed lines) of equimolar amounts of a1- or a3-peptide
are shown in panels C and D, respectively. (Insets) Difference spectra of
Ca2þ-CaM complexes with peptides minus Ca2þ-CaM.minimal. We found that only the a1- and a3-peptides bound
to Ca2þ-CaM, and formed 1:1 molar complexes with disso-
ciation constants of 1.23 mM and 3.57 mM, respectively (see
Table S1 in the Supporting Material). In the case of the
a2-peptide (including the central membrane-anchoring
motif), we did not observe any changes in heat upon its
titration into the CaM solution (not shown). Moreover, as
was expected, the interaction of the a1- and a3-peptides
with CaM was strongly Ca2þ-dependent.
Not surprisingly, both a1 and a3 exhibited an increase
in proportion of secondary structure components upon
binding with Ca2þ-CaM (Fig. 1, C and D). Analysis of
CD spectra suggests that two peptides underwent a transition
to predominantly an a-helical structure representative of
a standard target structure induced by interaction with
Ca2þ-CaM (57). We have previously modeled CaM with
peptide fragments of MBP constructed to be a-helical
(58), and this disorder-to-order transition is consistent
with this segment of MBP being an a-helical MoRF
(5,19,37). Moreover, the secondary structure propensity of
full-length 18.5-kDa recombinant murine MBP complexed
with Ca2þ-CaM previously indicated formation of a-helical
structure (19), and later with natural bovine MBP (21), but,
to our knowledge, the new CD data presented here with the
smaller peptides show this transition more clearly.
These results have further demonstrated that a1 contains
an additional binding domain for Ca2þ-CaM, which we have
previously postulated (18,58,59). Although the dissociation
constants for the interaction of peptides and Ca2þ-CaM
determined in our study are significantly higher than those
reported for the full-length recombinant or bovine MBP
(low nanomolar range) (18), our results are in agreement
with the Kd value calculated for a different C-terminal
MBP peptide designed in another study (10 mM) (20,21).
Moreover, these recent studies have suggested that CaM
binding to MBP is cooperative; thus, probably, the entire
sequence of MBP is required to bind with higher affinity
(compare (19–21)). These additional interactions explain
the differences in dissociation constants observed for
peptide segments and the full-length protein.Actin polymerization induced by MBP-a-peptides
and depolymerization induced by CaM
We have recently shown that there are at least two segments
in the 18.5-kDa mMBP sequence that cause actin polymer-
ization under otherwise nonpolymerizing conditions (17).
We were able to conclude that one site was located in the
N-terminal two-thirds of the protein, and the other in the
C-terminal two-thirds of the sequence. Additionally, we
have shown that the actin polymerization activity of the
N-terminal part was higher than for the C-terminal one,
but we could not obtain any other site-specific information
about the interaction. It was previously shown by others
that peptides derived by thrombin digestion of 18.5-kDaBiophysical Journal 101(5) 1248–1256
FIGURE 2 Actin polymerization and bundling induced by MBP-
a-peptides and the effect of Ca2þ-CaM. (A) Dependence of fluorescence
enhancement caused by actin polymerization on the molar ratio of
MBP-derived peptides to actin. All reactions were carried out in G-buffer
at 30C and contained 5 mM G-actin with various concentrations of
a1- (solid line), a2- (dashed line), and a3- (dashed-dotted line) peptides.
The a1-induced actin polymerization was probed also in the presence of
DPC (dash-dot-dotted line). The mean 5 SD of triplicates is shown.
Data points are expressed as (Fi-F0)/F0, where Fi is the fluorescence
intensity at different peptide/actin molar ratios and F0 is the fluorescence
intensity of 5 mMG-actin in G-buffer. (B) Time dependence of the increase
in fluorescence caused by polymerization of 1.1 nmol of G-actin induced
by 13.3 nmol of a1-peptide and decrease in fluorescence due to depolymer-
ization after the addition of 13.3 nmol of Ca2þ-CaM. (Arrows) Time of
a1-peptide and CaM addition. Shown is a representative experiment (out
of three replicates).
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and (R96–R168) segments, had strong actin-polymerizing
activity (61). (These two bovine 18.5-kDa MBP segments
correspond to the murine 18.5-kDa MBP segments (A1–
F43) and (R94–R167), respectively.) In another recent study
using Fourier transform infrared and solid-state NMR spec-
troscopy, we identified potential regions in MBP that might
undergo changes in secondary structure upon interaction
with actin (16). To gain further insight into these associa-
tions, it was important to probe the interaction with actin
of all three MBP-a-peptides (a1, a2, and a3), separately.
We used an increase in the fluorescence intensity of
pyrene-labeled actin as a measure of actin polymerization.
We then followed the rate of actin polymerization induced
by different concentrations of a1-, a2-, and a3-peptides, and
compared these results to the rate of full-length 18.5-kDa
MBP-induced activity (data not shown). It appeared that of
these three peptides, only a1 induced actin polymerization,
but at a rate much slower than that of the full-length rmMBP.
Typically, for the full-length protein, the maximal fluores-
cence intensity was observed after ~5 min, but it required
~20 min in the case of a1. As shown in Fig. 2 A, the titration
curve of an enhancement in fluorescence intensity upon
addition of increasing concentrations of a1 had a sigmoidal
shape.
At a molar ratio of ~6.5 (a1 to actin), saturation in the
level of actin polymerization was reached. We also exam-
ined the morphology of MBP-a-peptide/F-actin assemblies
by transmission electron microscopy (see Fig. S4). We
collected electron micrographs from samples where the
a-peptide/actin molar ratio was 4.5. Only with a1 did we
observe bundling of actin filaments, which appeared to be
morphologically indistinguishable from those assembled
by full-length protein (17). Yet, one can see that there
were many unbundled actin filaments in the background,
which typically were not present with the full-length protein.
Additionally, because we observed that under membrane-
mimetic conditions (presence of DPC at concentrations
higher than its critical micelle concentration), the a1-peptide
adopted a higher degree of secondary structure (see Fig. S3
D), we decided to test the ability of this peptide to poly-
merize actin and bundle filaments in the presence of DPC
micelles (Fig. 2 A and see Fig. S5). Clearly, the presence
of micelles enhanced the actin polymerization activity of
the peptide. The saturation in actin polymerization level
was achieved at an a1-peptide/actin molar ratio of ~4.5.
However, the presence of DPC did not appear to affect the
bundling ability of the peptide. Even at a molar ratio of
peptide/actin as high as eight, actin partially existed in its
unbundled filamentous form as derived from analysis of
the sedimentation assay (see Fig. S5 B).
Another important question for investigation was to detect
whether the a1-peptide tethered DPC micelles to actin upon
interaction. Because the only source of phosphorus in the
actin bundles could be DPC, we used a phosphorus assay toBiophysical Journal 101(5) 1248–1256quantify it in the actin-peptide complex after the sedimenta-
tion assay, as we have done previously (17). We found that
even though the a1-peptide represents only a small part of
MBP, it tethered DPC to the actin bundles at a ratio of one
micelle per one peptidemolecule, as ascertained by the phos-
phorus assay (data not shown). Furthermore, using the same
sedimentation assay, we quantified the amount of bound and
free peptide, after sedimentation of bundled actin from the
reaction mixtures with different initial actin/peptide molar
ratios, in the presence or absence of DPC. By plotting results
of fractional saturation [a1bound]/[actintotal] versus [a1free]
(see Fig. S5 C), we estimated that the affinity of peptide
binding to actin, in the presence and absence of DPC, was
in a low micromolar range. The dissociation constants
appeared to be 103-fold higher than those reported for the
MBP Functional Domains 1253full-length 18.5-kDa MBP (17), thus indicating weaker
binding. The shape of the binding curves suggested that there
was binding at a ratio of four peptide molecules per actin
molecule in the presence of DPC. However, in the absence
of DPC, the shape of the binding isotherm appeared to be
sigmoidal, thus signifying again that concentrations of
peptide higher than critical (to allow actin polymerization)
were required for binding.
Interestingly, the other two MBP-a-peptides (a2 and
a3)—which included the segments of 18.5-kDa mMBP
that, based on a previous solid-state NMR study (16), were
expected to interact with actin, such as Pro82Phe86 and
Ile90Pro96 (included in the a2-peptide); and Ser133His135
and Ala141Leu148 (included in the a3-peptide)—did not
induce any polymerization of actin. This result suggests
that the interaction between MBP and actin is not only
charge-based, but involves primarily the N-terminal domain.
It also could be that the a2- and a3-peptides were not long
enough, or did not include the other residues responsible
for actin polymerization caused by other segments of
18.5-kDa MBP. It is very likely that, in vivo, the synergistic
action of charge-based and region-specific interactions
between MBP and actin is required to polymerize actin effi-
ciently, especially in the environment of the oligodendrocyte
membrane, when parts of the protein are embedded in the
lipid bilayer, but not the charged residues that are available
for the interaction.
It has been shown in several previous studies, that Ca2þ-
activated CaM could reverse polymerization of actin by
MBP (12,13,15,62,63). Although we have previously shown
that the primary CaM-binding domain is located at the
C-terminus of MBP (18,19), in this study we have shown
that both a1- and a3-peptides bound Ca2þ-CaM (Fig. 1 and
see Table S1), and thus we examined here the ability of
Ca2þ-CaM to reverse a1-polymerized actin assembly
(Fig. 2B).We found that, indeed, Ca2þ-CaM instantly causedactin depolymerization. The rate appeared to be much faster
than in the case of full-length 18.5-kDa rmMBP (27). These
results suggest that Ca2þ-CaM caused dissociation of a1
from actin, because it alone is not directly involved in either
actin polymerization or depolymerization.
The rate of this dissociation was noticeably faster than for
the full-length MBP, probably because there is more than
one binding site in MBP to actin. In contrast to the binding
of full-length MBP to actin with the dissociation constant in
the low nanomolar range, peptide binding was characterized
by Kd in the micromolar range. Thus, Ca
2þ-CaM can effec-
tively compete with actin for peptide binding. Altogether,
these results proved not only that the a1-peptide contains
an additional binding domain for Ca2þ-CaM, but also that
this binding is important for CaM-induced actin depolymer-
ization. Similar control mechanisms have been observed
for other proteins like myristoylated alanine-rich C-kinase
substrate (64,65). Interestingly, another group has recently
shown that the N-terminal region of MBP inhibits the
formation of amyloid-b fibrils (66).Solution NMR spectroscopy
As of the time of this writing, we are using solution NMR
spectroscopy to investigate further the interactions of the
three peptides with other partners, namely Ca2þ-CaM
(9,19) and SH3-domains (32,44), and solid-state NMR
spectroscopy to study the a1-actin interaction (16). We
will only present here and in the Supporting Material initial
results on the interaction of the a3-peptide with Ca2þ-CaM.
Fig. 3 is an overlay of the 1H-15N-HSQC spectra of a3 alone
and in association with Ca2þ-CaM at a 1:1 molar ratio,
showing chemical shift perturbations and peak broadening
upon binding. These data indicate that almost the entire
a3-peptide is subject to dramatic changes in its immediate
chemical environment and/or structural state as a result ofFIGURE 3 Overlays of the 1H-15N-HSQC spectra for
the a3-peptide alone (green contours), and the a3-
peptide-Ca2þ-CaM complex (blue contours) at a 1:1 molar
ratio. Peak labels denote assignments for the free peptide
(black) and peptide in complex with Ca2þ-CaM (red).
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1254 Bamm et al.the interaction, and that the complexes are in fast confor-
mational or chemical exchange with their components.
Sequence-specific assignments of backbone resonances of
the a3-peptide alone (e.g., see Fig. S7, Table S3, and Table
S4) were used to identify the residues subject to these
changes, and the data in Fig. 3 indicate that the interaction
takes place along the whole peptide.
Titration with the chelating agents EDTA and EGTA
proved the interaction of the basic peptide with acidic
CaM to be Ca2þ-dependent and thus specific (and not
simply electrostatic), even if relatively weak (see Fig. S7).
Preliminary data on the interaction of the a1-peptide with
Ca2þ-CaM also show chemical shift perturbations indicative
of a structural reorganization of this Ca2þ-CaM-target (see
Fig. S8). In comparison with the a3-peptide, there is some-
what less peak broadening for the a1-peptide in association
with Ca2þ-CaM, and the peak shifts appear more linear as
opposed to curved (data not shown). Taken together, these
preliminary data suggest a more complex and dynamic
association of the a3-peptide with Ca2þ-CaM than for the
a1-peptide, which warrants further investigation. Studies
are continuing in our group to delineate further the nature
of these disorder-to-order transitions for both the a1- and
a3-peptides, as well as the synergistic association of the
whole protein, with Ca2þ-CaM, actin, and SH3-domains.CONCLUSIONS
The inherent structural flexibility of MBP is directly associ-
ated with its myriad membrane and protein associations, and
thus its multifunctionality (2,3,5,6,9). The interactions of
other intrinsically disordered proteins with various binding
partners have revealed themes of preformed structural
elements, ‘‘moonlighting’’ of specific binding segments,
and ‘‘fuzziness’’ (or structural plasticity) of the complexes
(67–71). The ‘‘fuzziness’’ has been previously demonstrated
in that much of full-length 18.5-kDa MBP is mobile even in
association with phospholipid membranes (34,35) or with
actin bundles (16,17).
Here, we have focused on three segments of MBP, which
we show to have an inherent a-helical structure even in
aqueous solution. Two of these regions (a2 and a3) have
previously been demonstrated experimentally to form
amphipathic a-helices in association with membranes
(33,34,36). Because the C-terminal a3-peptide has also
been demonstrated to be a Ca2þ-CaM-binding target (19,20),
it represents an example of ‘‘moonlighting’’ wherein it has
different associations and presumably different conforma-
tions in each environment (68). Although the N-terminal
segment of 18.5-kDa MBP encompassing the a1-peptide
associates with lipid bilayers (72), to our knowledge it has
yet to be characterized structurally in this state. Here, we
have shown that a1 is the minimal MBP segment required
to assemble actin, and that it also binds Ca2þ-CaM—another
example of ‘‘moonlighting’’.Biophysical Journal 101(5) 1248–1256SUPPORTING MATERIAL
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